Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Sponsor: Pfizer
Summary
The purpose of this study is to evaluate: * What is the real-world effectiveness of elranatamab in patients with relapsed and/or refractory multiple myeloma (RRMM) in Taiwan? * What are the baseline and clinical characteristics of RRMM patients who have received eltanatamab in Taiwan? * What are the treatment patterns of RRMM patients receiving elranatamab in the real-world setting in Taiwan?
Official title: A Multi-center Observational Study of the Effectiveness of Elranatamab in Patients With Relapsed and/or Refractory Multiple Myeloma in Taiwan
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-04-30
Completion Date
2028-01-31
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Interventions
Non intervention
Non intervention
Locations (4)
Kaohsiung Chang Gung Memorial Hospital
Kachsiung, Taiwan
Taichung Veterans General Hospital
Taichung, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan